Equities

Worldwide Healthcare Trust PLC

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Worldwide Healthcare Trust PLC

Actions
  • Price (EUR)4.02
  • Today's Change0.04 / 1.01%
  • Shares traded23.00
  • 1 Year change+1.52%
  • Beta0.5118
Data delayed at least 15 minutes, as of Feb 16 2026 07:10 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Worldwide Healthcare Trust PLC is a specialist investment trust. It invests in the global healthcare sector with the objective of achieving a high level of capital growth. It invests worldwide in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector. It will not invest more than 15% of the portfolio in any one individual stock at the time of acquisition. It invests over 50% of the portfolio in larger companies, and 20% of the portfolio in smaller companies. It may invest 5% of the portfolio, at the time of acquisition, in debt instruments, convertibles and royalty bonds issued by pharmaceutical and biotechnology companies. It may invest 40% of the portfolio in companies in the healthcare equipment and supplies sector and 30% of the portfolio in companies in the healthcare providers and services sector. Its alternative investment fund manager is Frostrow Capital LLP. OrbiMed Capital LLC is its portfolio manager.

  • Revenue in GBP (TTM)-148.71m
  • Net income in GBP-168.47m
  • Incorporated1995
  • Employees0.00
  • Location
    Worldwide Healthcare Trust PLCFrostrow Capital LLP25 Southampton BuildingsLONDON WC2A 1ALUnited KingdomGBR
  • Phone+44 203 008 4910
  • Websitehttps://www.worldwidewh.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.